Structural and Sociocultural Factors Associated with Cervical Cancer Screening Among HIV-infected African American Women in Alabama

Overview

Journal AIDS Patient Care STDS

Specialty Infectious Diseases

Date 2014 Dec 17

PMID 25514125

Citations 22

Authors

Michelle Williams

Linda Moneyham

Mirjam-Colette Kempf

Eric Chamot

Isabel Scarinci

Affiliations

Soon will be listed here.

Abstract

African American women have disproportionately high prevalence rates of HIV and cervical cancer. HIV-infected women are significantly less likely to obtain recommended cervical cancer screenings than HIV-uninfected women. The purpose of this study was to examine sociocultural and structural factors associated with cervical cancer screening among HIV-infected African American in Alabama. The PEN-3 Model and the Health Belief Model were used as theoretical frameworks. In-depth interviews were conducted with twenty HIV-infected African American women to identify perceptions, enablers, and nurturers, perceived susceptibility, perceived severity, and perceived benefits related to cervical cancer and screening. The most common positive perceptions, enablers, and nurturers that contributed to cervical cancer screening included internal motivation and awareness of the importance of HIV-infected women getting Pap tests due to their weakened immune system. Negative perceptions, enablers, and nurturers included lack of knowledge about cervical cancer and screening, and lack of perceived susceptibility to cervical cancer. The results of this study can be used to guide the development of culturally relevant cervical cancer and screening education interventions aimed at increasing cervical cancer screening adherence among HIV-infected African American women.

Citing Articles

HIV prevalence among cervical (pre)cancer diagnoses in Suriname: a retrospective population study.

Stijnberg D, Charles R, Mc Kee M, Chan M, Grunberg A, Schrooten W Rev Panam Salud Publica. 2024; 48:e122.

PMID: 39529690 PMC: 11552060. DOI: 10.26633/RPSP.2024.122.

Case example of a jail-based cancer prevention clinical trial: Social determinants of health framework, novel experimental design, and retention strategies to facilitate long-term follow-up of clinical trial participants.

Kennedy P, Ratnaparkhi R, Lee J, Glenn J, Kelly P, Kimminau K J Clin Transl Sci. 2023; 7(1):e163.

PMID: 37588675 PMC: 10425866. DOI: 10.1017/cts.2023.561.

Predictive power of PEN-3 cultural model in cervical cancer screening among women: a cross- sectional study in South of Iran.

Dadipoor S, Alavi A, Kader Z, Mohseni S, Eshaghi Sani Kakhaki H, Shahabi N BMC Cancer. 2023; 23(1):730.

PMID: 37553636 PMC: 10408223. DOI: 10.1186/s12885-023-11240-3.

Cervical Cancer Screening Knowledge, Perceptions, and Behaviors in a Multiracial Cohort of Low-Income, Underscreened Women in North Carolina.

Bukowski A, Smith J, Wheeler S, Sanusi B, McGuire F, Zeno E J Womens Health (Larchmt). 2023; 32(9):970-981.

PMID: 37327372 PMC: 10510685. DOI: 10.1089/jwh.2022.0412.

Effectiveness of educational intervention on women's participation to cervical cancer screening: a quasi-experimental study based on PEN-3 model.

Seyrafi N, Homayuni A, Hosseini Z, Aghamolaei T, Ghanbarnejad A, Mouseli A BMC Cancer. 2022; 22(1):1226.

PMID: 36443696 PMC: 9703409. DOI: 10.1186/s12885-022-10331-x.

References

Tebeu P, Major A, Mhawech P, Rapiti E . The recurrence of cervical intraepithelial neoplasia in HIV-positive women: a review of the literature. Int J STD AIDS. 2006; 17(8):507-11. DOI: 10.1258/095646206778145703. View

Hewitt M, Devesa S, Breen N . Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004; 39(2):270-8. DOI: 10.1016/j.ypmed.2004.03.035. View

Blitz S, Baxter J, Raboud J, Walmsley S, Rachlis A, Smaill F . Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis. 2013; 208(3):454-62. DOI: 10.1093/infdis/jit181. View

Keller M, Burk R, Xie X, Anastos K, Massad L, Minkoff H . Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection. JAMA. 2012; 308(4):362-9. PMC: 3556987. DOI: 10.1001/jama.2012.5664. View

Luszczynska A, Durawa A, Scholz U, Knoll N . Empowerment beliefs and intention to uptake cervical cancer screening: three psychosocial mediating mechanisms. Women Health. 2012; 52(2):162-81. DOI: 10.1080/03630242.2012.656187. View

Heard I . Prevention of cervical cancer in women with HIV. Curr Opin HIV AIDS. 2009; 4(1):68-73. DOI: 10.1097/COH.0b013e328319bcbe. View

White K, Garces I, Bandura L, McGuire A, Scarinci I . Design and evaluation of a theory-based, culturally relevant outreach model for breast and cervical cancer screening for Latina immigrants. Ethn Dis. 2012; 22(3):274-80. PMC: 3762980. View

Patel N, Rollison D, Barnholtz-Sloan J, MacKinnon J, Green L, Giuliano A . Racial and ethnic disparities in the incidence of invasive cervical cancer in Florida. Cancer. 2009; 115(17):3991-4000. DOI: 10.1002/cncr.24427. View

Beech B, Scarinci I . Smoking attitudes and practices among low-income African-Americans: qualitative assessment of contributing factors. Am J Health Promot. 2003; 17(4):240-8. DOI: 10.4278/0890-1171-17.4.240. View

10.

Airhihenbuwa C . A conceptual model for culturally appropriate health education programs in developing countries. Int Q Community Health Educ. 2010; 11(1):53-62. DOI: 10.2190/LPKH-PMPJ-DBW9-FP6X. View

11.

Brown D, Wilson R, Boothe M, Harris C . Cervical cancer screening among ethnically diverse black women: knowledge, attitudes, beliefs, and practices. J Natl Med Assoc. 2011; 103(8):719-28. DOI: 10.1016/s0027-9684(15)30411-9. View

12.

Watson M, Saraiya M, Benard V, Coughlin S, Flowers L, Cokkinides V . Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008; 113(10 Suppl):2855-64. DOI: 10.1002/cncr.23756. View

13.

Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A . Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes Control. 2009; 20(7):1129-38. DOI: 10.1007/s10552-009-9317-z. View

14.

Bazargan M, Bazargan S, Farooq M, Baker R . Correlates of cervical cancer screening among underserved Hispanic and African-American women. Prev Med. 2004; 39(3):465-73. DOI: 10.1016/j.ypmed.2004.05.003. View

15.

. ACOG Practice Bulletin No. 117: Gynecologic care for women with human immunodeficiency virus. Obstet Gynecol. 2010; 116(6):1492-1509. DOI: 10.1097/AOG.0b013e3182054cae. View

16.

Logan J, Khambaty M, DSouza K, Menezes L . Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDS. 2010; 24(8):471-5. DOI: 10.1089/apc.2009.0295. View

17.

Scarinci I, Bandura L, Hidalgo B, Cherrington A . Development of a theory-based (PEN-3 and Health Belief Model), culturally relevant intervention on cervical cancer prevention among Latina immigrants using intervention mapping. Health Promot Pract. 2011; 13(1):29-40. PMC: 3982834. DOI: 10.1177/1524839910366416. View

18.

Fletcher F, Vidrine D, Tami-Maury I, Danysh H, King R, Buchberg M . Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic. AIDS Behav. 2013; 18(3):544-54. PMC: 4383031. DOI: 10.1007/s10461-013-0480-6. View

19.

Massad L, Evans C, Minkoff H, Watts D, Strickler H, Darragh T . Natural history of grade 1 cervical intraepithelial neoplasia in women with human immunodeficiency virus. Obstet Gynecol. 2004; 104(5 Pt 1):1077-85. DOI: 10.1097/01.AOG.0000143256.63961.c0. View

20.

Rosenstock I . Why people use health services. Milbank Mem Fund Q. 1966; 44(3):Suppl:94-127. View